Over-expression of IRF4 in CLL cells reduces BCR signaling, including BCR-induced AKT and ERK phosphorylation and calcium release, and this effect has been proposed to be mediated at least partially through decreased expression of SYK and IKAROS [41]. Here, IRF4 is linked to B-cell chronic lymphocytic leukemia.